2nd Quarter - Amendment
SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2013 | $280,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 26, 2013 | $290,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions related to the IPAB Issues regarding general health care reform (no specific bill#) Essential Health Benefits Discussions regarding Perscription Drug User Fee Act (PDUFA) Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Copyright/Patent/Trademark CPT
Discussions regarding patent reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Medicare/Medicaid MMM
Issues regarding Medicare Part D, Medicare reimbursement issues Discussions regarding Medicare Part B
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.